India: Covaxin for children soon, 2-18 years age group
#1

According to reliable sources, the Hyderabad-based company is currently engaged in immunogenecity studies of the vaccine in the 2-18 years age group after ‘satisfactory’ outcome in the clinical trials.

https://www.thehindubusinessline.com/com...004481.ece
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)